← Back to headlines
ImmunityBio Inc. under investigation for federal securities law violations
ImmunityBio Inc. (NASDAQ: IBRX) is reportedly being investigated for potential violations of federal securities laws by Lowey Dannenberg, P.C.
29 Apr, 16:51 — 29 Apr, 16:51


